179 related articles for article (PubMed ID: 12356806)
1. Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level.
Reinhardt AK; Kempf I; Kobisch M; Gautier-Bouchardon AV
J Antimicrob Chemother; 2002 Oct; 50(4):589-92. PubMed ID: 12356806
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mutations in DNA gyrase and topoisomerase IV Involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro.
Reinhardt AK; Bébéar CM; Kobisch M; Kempf I; Gautier-Bouchardon AV
Antimicrob Agents Chemother; 2002 Feb; 46(2):590-3. PubMed ID: 11796386
[TBL] [Abstract][Full Text] [Related]
3. [Role of mutations in parC and gyrA in forming resistance of Mycoplasma hominis to fluoroquinolones].
Gushchin AE; Ladygina VG; Govorun VM
Mol Gen Mikrobiol Virusol; 1999; (4):19-24. PubMed ID: 10621934
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between minimal inhibitory concentration to enrofloxacin and mutations present in the quinolone-resistance determining regions of Mycoplasma gallisepticum field strains.
Lysnyansky I; Gerchman I; Levisohn S; Mikula I; Feberwee A; Ferguson NM; Noormohammadi AH; Spergser J; Windsor HM
Vet Microbiol; 2012 Nov; 160(1-2):222-6. PubMed ID: 22655973
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization and typing of enrofloxacin-resistant clinical isolates of Mycoplasma gallisepticum.
Lysnyansky I; Gerchman I; Perk S; Levisohn S
Avian Dis; 2008 Dec; 52(4):685-9. PubMed ID: 19166064
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance.
Hirose K; Kawasaki Y; Kotani K; Abiko K; Sato H
J Vet Med B Infect Dis Vet Public Health; 2004 May; 51(4):169-75. PubMed ID: 15228551
[TBL] [Abstract][Full Text] [Related]
7. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.
Bébéar CM; Grau O; Charron A; Renaudin H; Gruson D; Bébéar C
Antimicrob Agents Chemother; 2000 Oct; 44(10):2719-27. PubMed ID: 10991851
[TBL] [Abstract][Full Text] [Related]
8. Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro.
Bébéar CM; Renaudin H; Charron A; Bové JM; Bébéar C; Renaudin J
Antimicrob Agents Chemother; 1998 Sep; 42(9):2304-11. PubMed ID: 9736554
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
10. Investigation of fluoroquinolone resistance mechanism in Mycoplasma hominis isolated from urogenital samples in a Chinese hospital.
Zhang H; Zheng L; Zhao J; Ding S; Xia Y
J Med Microbiol; 2019 Feb; 68(2):206-210. PubMed ID: 30632961
[TBL] [Abstract][Full Text] [Related]
11. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.
Dessus-Babus S; Bébéar CM; Charron A; Bébéar C; de Barbeyrac B
Antimicrob Agents Chemother; 1998 Oct; 42(10):2474-81. PubMed ID: 9756744
[TBL] [Abstract][Full Text] [Related]
12. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones.
Pan XS; Fisher LM
Antimicrob Agents Chemother; 1997 Feb; 41(2):471-4. PubMed ID: 9021211
[TBL] [Abstract][Full Text] [Related]
13. Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones.
Pan XS; Hamlyn PJ; Talens-Visconti R; Alovero FL; Manzo RH; Fisher LM
Antimicrob Agents Chemother; 2002 Aug; 46(8):2498-506. PubMed ID: 12121924
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in quinolone resistance in Mycoplasma mycoides subsp. capri.
Antunes NT; Assunção P; Poveda JB; Tavío MM
Vet J; 2015 Jun; 204(3):327-32. PubMed ID: 25951987
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field.
Giraud E; Brisabois A; Martel JL; Chaslus-Dancla E
Antimicrob Agents Chemother; 1999 Sep; 43(9):2131-7. PubMed ID: 10471553
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones.
Bebear CM; Bové JM; Bebear C; Renaudin J
Antimicrob Agents Chemother; 1997 Feb; 41(2):269-73. PubMed ID: 9021178
[TBL] [Abstract][Full Text] [Related]
18. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
[TBL] [Abstract][Full Text] [Related]
19. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
Weigel LM; Anderson GJ; Facklam RR; Tenover FC
Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.
Talukder KA; Khajanchi BK; Islam MA; Islam Z; Dutta DK; Rahman M; Watanabe H; Nair GB; Sack DA
Curr Microbiol; 2006 Feb; 52(2):108-11. PubMed ID: 16450072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
